恒瑞医药：拟以10亿元-20亿元回购公司股份

Group 1 - The company plans to use a total fund amount of no less than RMB 1 billion and no more than RMB 2 billion to repurchase its A-shares through centralized bidding [1] - The repurchased shares are intended for the company's A-share employee stock ownership plan [1] - The total amount of funds for the repurchase will be completed within 12 months after the board of directors' approval [1]